期刊文献+

乳腺MRI与乳腺X线在导管原位癌临床诊断中应用的比较研究 被引量:6

Application Comparison of Mammography MRI and Breast X-ray in Clinical Diagnosis for Ductal Carcinoma in Situ
原文传递
导出
摘要 目的:探讨乳腺MRI与乳腺X线检查在导管原位癌(DCIS)诊断中的应用价值。方法:选择2012年5月至2014年9月在我院接受诊治的乳腺DCIS患者52例(58个病灶)为研究对象,对所有患者进行乳腺MRI及X线检查,以病理检查结果作为金标准,比较乳腺MRI及X线检查在导管原位癌(DCIS)诊断中的应用价值。结果:58个病灶中,乳腺MRI共检查出阳性54例,阴性4例,其中误诊或漏诊4例;乳腺X线共检查出阳性49例,阴性9例,其中误诊或漏诊11例。乳腺MRI检查的灵敏度和准确度均显著高于乳腺X线,差异有统计学意义(P<0.05)。此外,乳腺MRI检查的特异度、阳性预测值及阴性预测值均分别高于乳腺X线,但差异无统计学意义(P>0.05)。结论:乳腺MRI检查对DCIS的诊断价值较高,具有广泛的应用前景,但亦存在少数误诊或漏诊。 Objective:To study the application value of mammography MRI and breast X-ray in the diagnosis of ductal carcinoma in situ(DCIS).Methods:From May 2012 to September 2014 52 patients(58 lesions) with the diagnosis and treatment of breast DCIS patients in our hospital were studied.For all patients with breast MRI and X-ray diagnosis of DCIS,the pathological examination results was as the gold standard,compared breast MRI and X-ray's diagnosis value.Results:In the 58 lesions,breast MRI were detected in 54 cases of positive,negative in 4 cases.The true positive in 51 cases,misdiagnosis or missed diagnosis was 4 cases.Breast X-ray detected a total of 49 cases were positive,9 were negative.The true positive in 46 cases,misdiagnosis or missed diagnosis was 11 cases.The sensitivity and accuracy of MRI was significantly higher than that in breast breast X-ray,the difference was statistically significant(P0.05).In addition,specificity,positive predictive value of breast MRI and negative predictive value were higher than breast x-ray,the difference was statistically significant(P0.05).Conclusion:The high value of breast MRI in the diagnosis of DCIS,has a wide application prospect,but there are also a handful of misdiagnosis or missed diagnosis.
出处 《现代生物医学进展》 CAS 2016年第6期1089-1091,1200,共4页 Progress in Modern Biomedicine
基金 河北省秦皇岛市2012年市科技支撑计划项目(201201B033)
关键词 乳腺MRI 乳腺X线 导管原位癌 诊断 Mammography MRI Breast X-ray Ductal carcinoma in situ Diagnosis
  • 相关文献

参考文献20

  • 1Tran TA, Deavers MT, Carlson JA, et al. Collision of Ductal Carcinomaln Situ of Anogenital Mammary-like Glands and Vulvar Sarcomatoid Squamous Cell Carcinoma [J]. Int J Gynecol Pathol, 2015, 34(5): 487-94.
  • 2Pickles MD, Gibbs P, Hubbard A, et al. Comparison of 3.0T magnetic resonance imaging and X-my mammography in the measurement of ductal carcinoma in situ:A comparison with histopathology [J]. Eur J gadiol, 2015, 84(4): 603-610.
  • 3Dereere E, Papadimitriou K, Tjalma W, et al. Duotal carcinomain situ:a disease entity that merits more recognition [J]. Minerva Chit,2015, 70(4): 231-239.
  • 4Reimers LL, Sivasubramanian PS, Hershman D, et al. Breast Cancer Chemoprevention among High-risk Women and those with Ductal CarcinomaIn Situ[J]. Breast J, 2015, (4): 377-386.
  • 5Kuerer HM. Ductal carcinomain situ:treatment or active surveillance? [J]. Expert Rev Anticancer Ther, 2015, 15(7): 777-785.
  • 6Sailer V, Lu ders C, Kulm W, et al. Immunostaining of Np63 (using the p40 antibody) is equal to that of p63 and CK5/6 in high-grade ductal carcinomain situ of the breast [J]. Virchows Arch, 2015, 467 (1): 67-70.
  • 7Koh VC, Lim JC, Thike AA, et al. Characteristics and behaviour of screen-detected ductal carcinomain situ of the breast: comparison with symptomatic patients[J]. Breast Cancer Rcs Treat, 2015, 152 (2): 293-304.
  • 8Coromilas E J, Wright JD, Huang Y, et al. The Influence of Hospital and Surgeon Factors on the Prevalence of Axillary Lymph Node Evaluation in Ductal CarcinomaIn Situ [J]. JAMA Oncol, 2015, 1(3): 323-332.
  • 9Bickel H, Pinker-Domenig K, Bogner W, et al. Quantitative apparent diffusion coefficient as a noninvasive imaging biomarker for the differentiation of invasive breast cancer and ductal carcinoma in situ [J]. Invest Radiol, 2015, 50(2): 95-100.
  • 10尹喜,蒋涛,刘小娟,刘锦锋,李敏,刘东婷,王文川.动态增强MRI检查分级评估良恶性乳腺团块型病灶的价值[J].中华放射学杂志,2011,45(12):1104-1107. 被引量:12

二级参考文献36

  • 1Baum F,Fischer U,Vosshenrich R,et al.Classification of hypervascularized lesions in CE MR imaging of the breast.Eur Radio1,2002,12:1087-1092.
  • 2American College of Radiology.Breast imaging reporting and data system (BI-RADS).4th ed.Reston,VA:American College of Radiology (ACR),2003:1-50.
  • 3Tardivon AA,Athanasiou A,Thibault F,et al.Breast imaging and reporting data system (BIRADS):magnetic resonance imaging.Eur J Radiol,2007,61:212-215.
  • 4Tardivon AA,Athanasiou A,Thibault F,et al.Breast imaging and reporting data system (BIRADS) magnetic resonance imaging illustrated cases.Eur J Radiol,2007,61:216-223.
  • 5Nunes LW,Schnall MD,Orel SG.Update of breast MR imaging architectural interpretation model.Radiology,2001,219:484-494.
  • 6G(o)kalp G,Topal U.MR imaging in probably benign lesions (BIRADS category 3) of the breast.Eur J Radiol,2006,57:436-444.
  • 7Kuhl C.The current status of breast MR imaging.Part Ⅰ.Choice of technique,image interpretation,diagnostic accuracy,and transfer to clinical practice.Radiology,2007,244:356-378.
  • 8Stines J.BI-RADS:use in the French radiologic community.How to overcome with some difficulties.Eur J Radiol,2007,61:224-234.
  • 9Warren RM,Pointon L,Thompson D,et al.Reading protocol for dynamic contrast-enhanced MR images of the breast:sensitivity and specificity analysis.Radiology,2005,236:779-788.
  • 10Vizcaíno I,Gadea L,Andreo L,et al.Short-term follow-up results in 795 nonpalpable probably benign lesions detected at screening mammography.Radiology,2001,219:475-483.

共引文献15

同被引文献35

引证文献6

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部